Abstract Disclosure: A.L. Messersmith: None. E. Piervil: None. R. Meadows: None. K. Patel: None. E. Griffin: None. Diabetes disproportionately impacts racial/ethnic minorities. According to 2017-2020 National Health and Nutrition Surveys (NHANES) data, prevalence of diabetes was greater among black non-Hispanic, Asian non-Hispanic, and Hispanic populations compared to white non-Hispanic (Prevalence of Both Diagnosed, 2022). Acculturation, the process by which an individual integrates the attitudes, values, beliefs, and behaviors of a different culture, has also been associated with diabetes (Allen, 2014; O'Brien, 2014). This study incorporates 2013-2018 NHANES data to assess the association between acculturation and diabetes management. Country of birth, years living in the U.S., and primary language spoken at home will serve as proxies for acculturation. This study includes 2,442 individuals who were ever told by a doctor or health professional that they had diabetes (gestational diabetes excluded) with 784 of these participants born outside the U.S. Comparatively 492 individuals with no known history of diabetes had lab results drawn during the NHANES survey supporting newly diagnosed diabetes (A1c ≥6.5), 213 of whom were immigrants. Socioeconomic status and access to health care and health insurance are factors that likely mediate the relationship between acculturation and diabetes control. Initial data analysis found 38% of immigrants with laboratory and/or health professional diagnosed diabetes lived below the poverty level compared to 20% of U.S.-born individuals. Health insurance coverage was 81% among immigrants compared to 92% among U.S.-born individuals. This study will utilize logistic regression to explore the association between acculturation and diabetes. Compliance of individuals living with diabetes to American Diabetes Association screening recommendations will be assessed. Descriptive statistics will be summarized and include demographics, comorbid diseases, body mass index (BMI), cumulative years with diagnosed diabetes, insulin and/or oral antihyperglycemic diabetes therapy, insurance coverage, and frequency of doctor visit(s).
Read full abstract